In vitro inhibitory effect of Berberis vulgaris (Berberidaceae) and Its main component, Berberine against different leishmania species

Iranian Journal of Parasitology

Volumn 9, Issue 1, 2014, Pages 28-36

  Mahmoudv, Hossein ^a,b   Sharififar, Fariba ^a   Sharifi, Iraj ^b   Ezatpour, Behrouz ^c   Fasihi Harandi, Majid ^a   Makki, Mahsa Sadat ^d   Zia Ali, Naser ^a   Jahanbakhsh, Sareh ^a,b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Berberine; Berberis vulgaris; In vitro; Leishmania infantum; Leishmania tropica

Indexed keywords

BERBERIS VULGARIS EXTRACT; MEGLUMINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

AMASTIGOTE; ANTIPROTOZOAL ACTIVITY; ARTICLE; BERBERIDACEAE; BERBERIS VULGARIS; CELL VIABILITY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IC 50; INFECTION CONTROL; LEISHMANIA; MACROPHAGE; NONHUMAN; PLANT ROOT; PROMASTIGOTE; PUBLIC HEALTH PROBLEM;

EID: 84896037115     PISSN: 17357020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. World Health Organization. Control of the Leishmaniasis. Geneva: WHO (Technical Report Series 949) 2010; 5-12.
2. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004; 27: 305-18.
3. Sharifi F, Sharifi I, Zarean M Parizi MH, Aflatoonian M, Harandi MF, et al. Spatial distribution and molecular identification of Leishmania species from endemic foci of South-eastern Iran. Iranian J Parasitol. 2012; 7(1): 45-52.
4. Mahmoudvand H, Mohebali M, Sharifi I, Keshavarz H, Hajjaran H, Akhoundi B, et al. Epidemiological aspects of visceral leishmaniasis in Baft district, Kerman province, Southeast of Iran. Iranian J Parasitol 2011; 6(1): 1-11.
5. Mohebali M. Visceral leishmaniasis in Iran: Review of the Epidemiological and Clinical Features. Iranian J Parasitol. 2013; 8(3): 348-58
6. Kedzierski L, Sakthianandeswaren A, Curtis JM, Andrews PC, Junk PC, Kedzierska K. Leishmaniasis: current treatment and prospects for new drugs and vaccines. Current Med Chem. 2009;16 (5): 599-614.
7. Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microb Rev. 2006; 19(1):11-26.
8. Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M. Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med. 2006; 3(5): e162. 659-67.
9. Santos DO, Coutinho CE, Madeira MF, Bottino CG, Vieira RT, Nascimento SB, et al. Leishmaniasis treatment a challenge that remains: a review. Parasitol Res. 2004; 103: 1-10.
10. Pour R, Sharifi I, Kazemi B, Zarean M. Identification of nonresponsive isolates to glucantime in patients with cutaneous leishmaniasis in Bam. J Kerman Univ Med Sci. 2011; 18(2):123-33.
11. Rocha LG, Almeida JR, Macedo RO, Barbosa-Filho JM. A review of natural products with antileishmanial activity. Phytomedicine. 2005; 12: 514-35.
12. Imanshahidi H, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, Berberine. Phytother Res. 2008; 22: 999-1012.
13. Ivanovska N, Philipov S. Study of the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int J Immunopharmacol. 1996;18: 553-61.
14. Küpeli E, Koar M, Yeilada E, Hüsnü K, Baer C. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sci. 2002; 72: 645-57.
15. Nakamoto K, Sadamori S, Hamada T. Effects of crude drugs and berberine hydrochloride on the activities of fungi. J Prosthet Dent. 1990; 64(6): 691-4.
16. Freile ML, Giannini F, Pucci G, Sturniolo A, Rodero L, Pucci O, et al. Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis heterophylla. Fitoterapia. 2003; 74: 702-5.
17. Ghaderi R, Maleki Nejad P. evaluation of anti-candidal effects of Berberis Vulgaris root extracts (methanolic and aqueous) and comparing their effects with those clotrimazole. J Birjand Univ Med Sci. 2006;13(2): 42-8.
18. Vennerstrom JL, Lovelace JK, Waits VB, Hanson WL, Klayman DL. Berberine derivatives as antileishmanial drugs. Antimicrob Agent Chemother. 2005; 34(5):198-211.
19. Kaneda Y, Torii M, Tanaka T, Aikawa M. In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis. Ann Trop Med Parasitol. 1991; 85: 417-25.
20. Shokri A, Sharifi I, Khamesipour A, Nakhaee N, Fasihi Harandi M, Nosratabadi J, et al. The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate. Parasitol Res. 2012; 110(3): 1113-17.
21. Garcia M, Monzote L, Scull R, Herrera P. Activity of Cuban plants extracts against Leishmania amazonensis. ISRN Pharmacol. 2012; 104540. doi: 10.5402/2012/104540. Epub 2012 Mar 15.
22. Weninger B, Robledo S, Arango GJ, Deharo E, Arango R, Munoz V, et al. Antiprotozoal activities of Colombian plants. J Ethnopharmacol. 2001; 78: 193-200.
23. Cowan MM. Plant products as antimicrobial agents. Clin Microb Rev. 1999; 12: 564-82.
24. McCutcheon AR, Ellis SM, Hancock RE, Tower GN. Antibiotic screening of medicinal plants of the British Columbian native peoples. J Ethnopharmacol. 1992; 37: 213-23.
25. Khadem Erfan MB, Mohebali M, Kazemi-Rad E, Hajjaran H, Edrissian GH, Mamishi S, et al. Downregulation of calcineurin gene is associated with Glucantime® resiatance in Leishmania infantum. Iranian J Parasitol. 2013; 8(3): 359-66.
26. Kazemi-Rad E, Mohebali M, Khadem-Erfan MB, Saffari M, Raoofian R, Hajjaran H, et al. Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach. Exp Parasitol. 2013; 135: 344-9.
27. Fata A, Rakhshandeh H, Berenji F, Jalalifard A. treatment of cutaneous leishmaniasis in murine model by alcoholic extract of Berberis vulgaris. Iranian J Parasitol. 2006; 1(1): 39-42.
28. Sheng WD, Jiddawi MS, Hong XQ, Abdulla SM. Treatment of chloroquine-resistant malaria using pyrimethamine in combination with berberine, tetracycline or cotrimoxazole. East Afr Med J. 1997; 74: 283-4.
29. Peychev L. Pharmacological investigation on the cardiovascular effects of Berberis vulgaris on tested animals. Pharmacia. 2005; 52: 118-21.
30. Lin CC, Ng LT, Hsu FF, Shieh DE, Chiang LC. Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth. Clin Exp Pharmacol Physiol. 2004; 31: 65-9.